News

Researchers at ETH Zurich and Bern University Hospital have developed a method for predicting circulatory failure in patients in intensive care units – enabling clinicians to intervene at an early stage. Their approach uses machine learning methods to evaluate an extensive body of patient data.

Scientists at Osaka University built a new computing device from field-programmable gate arrays (FPGA) that can be customized by the user for maximum efficiency in artificial intelligence applications.

A novel drug-delivery technology that uses a harmless virus to deliver an antibody gene into human cells can lead to sustained antibody production; this strategy could be applied to other infectious diseases.

Using a skin cream infused with microscopic STAR particles and a therapeutic drug, a team from the Georgia Institute of Technology has created a therapy that could facilitate better treatment of skin diseases.

A team from the St. Jude Children’s Research Hospital has discovered a gene linked with approximately 50% of glucocorticoid resistance cases in children with the most common pediatric cancer.

On 6 March, the International Space Station resupply mission Space X CRS-20 took off from Cape Canaveral. On board: 250 test tubes from the University of Zurich containing adult human stem cells. These stem cells will develop into bone, cartilage and other organs during the month-long stay in space.

Opioid prescriptions have been a known driver of the opioid epidemic, and it's now known that opioid prescriptions that last longer than five days are a risk factor for longer-term opioid use. A recent solution has been enacted where surgeons implemented a pain management program that reduced longer-term prescriptions by two-thirds.

Scientists from a Medical University of Vienna start-up may have found a way to stop rhinovirus and therefore might have discovered a new therapy for treating colds in the future.

A new study reveals that bias and stereotyping exist among clinical and research professionals recruiting patients into cancer clinical trials.

A new method of bioprinting uses aspiration of tiny biologics such as spheroids, cells and tissue strands, to precisely place them in 3D patterns either on scaffolding or without to create artificial tissues with natural properties.